Showing 15 posts of 1050 posts found.

AstraZeneca announces positive results from phase 3 trial for Tagrisso plus chemotherapy

May 17, 2023
Research and Development AstraZeneca, Cancer, Oncology, Tagrisso, chemotherapy

AstraZeneca has announced positive results from the FLAURA2 phase 3 trial which showed that Tagrisso (osimertinib), in combination with chemotherapy, …

Thermo Fisher and Pfizer collaborate on NGS-based cancer tests

May 10, 2023
Medical Communications Cancer, NGS, Oncology, Pfizer, Thermo Fisher Scientifitic, oncology

Scientific equipment provider Thermo Fisher and US pharmaceutical firm Pfizer have announced a collaboration to advance next-generation sequencing (NGS)-based cancer …


‘It’s Time for Trodelvy’: Charity launches petition against Gilead for drug access

July 19, 2021
Sales and Marketing Cancer, Gilead, NHS, charity

The charity Breast Cancer Now has launched a petition calling on Gilead to provide free-of-charge access to its new treatment …


Personalised medicine in oncology: Where are we now?

June 30, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …

Breakthrough announced in circulating tumour cell research

June 18, 2021
Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology

Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …

New class of cancer-killing drugs identified

June 18, 2021
Medical Communications Cancer, oncology

Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer …

BMS announce new positive data from oesophageal cancer study

June 4, 2021
Medical Communications Cancer, oncology

Bristol Myers Squibb (BMS) has announced results from the Phase III CheckMate -648 trial in which nivolumab plus chemotherapy and …

Researchers find possible new treatment for several cancers

April 23, 2021
Medical Communications Cancer, The Institute of Cancer Research, cancer treatment, kidney cancer treatment, pharma, pharma news

Researchers at The Institute of Cancer Research (ICR) in London have discovered a new use for an ovarian and breast …

Amgen flag

Amgen stomach cancer drug awarded Breakthrough Therapy Designation

April 21, 2021
Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news

Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …

BC Platforms partners with Australian Tissue Bank to improve breast cancer treatment

April 13, 2021
Manufacturing and Production Cancer, data

BC Platforms have announced a data partnership with the Australian Breast Cancer Tissue Bank (ABCTB) for its Global Data …

EC approves combination treatment for kidney cancer

March 31, 2021
Research and Development Cancer, Europe, oncology

The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line treatment for advanced renal cell …

NHS agrees on MSD interim colorectal cancer treatment

March 25, 2021
COVID-19, Cancer, MSD, NHS

MSD has announced a provisional agreement with the NHS to make KEYTRUDA (pembrolizumab) available for eligible patients with metastatic MSI-H/dMMR …

eTheRNA awarded €6.9 million TIGER Grant by European Commission

March 22, 2021
Sales and Marketing Cancer, EU

eTheRNA immunotherapies, a clinical-stage company, has been awarded a grant of €6.9 million by the European Commission to develop a …

Antion launch new technology for cancer and tumour treatments

March 18, 2021
Cancer, action, blood cancer, myeloma

Antion Biosciences has launched a new T-cell technology platform to help with the development of new curative therapies for diseases …

PEP-Therapy and Institut Curie’s cancer drug trial approved in France

March 17, 2021
Research and Development Cancer, France, Pep-therapy

PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to …

Latest content